Camelot Portfolios, LLC Takeda Pharmaceutical CO LTD Transaction History
Camelot Portfolios, LLC
- $156 Million
- Q4 2025
A detailed history of Camelot Portfolios, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Camelot Portfolios, LLC holds 387 shares of TAK stock, worth $5,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
387Holding current value
$5,530% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
385Shares Held
78.8MCall Options Held
1.67MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Ubs Group Ag4.12MShares$58.9 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...